ArticleOncology letters2022

Identification of novel prognostic factors focusing on clinical outcomes in patients with non-small cell lung cancer after stereotactic body radiotherapy.

Hikari Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.